The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
June 11th 2025
The expansion marks glecaprevir/pibrentasvir as the first and only indicated direct-acting antiviral approved for acute hepatitis C virus (HCV) infection.
FDA Lists New Drug Interactions for Victrelis
February 9th 2012The FDA sent out a "Drug Safety Communication" from their Division of Drug Information on February 9, 2012, listing the important new drug interactions between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitor drugs.
Read More
Counseling Patients with the Difficult Diagnosis of Hepatitis C
February 15th 2010Hepatitis C can be a challenging disease for patients. Pharmacists can be instrumental in educating their patients about the pharmacologic agents available for treatment and provide them with valuable resources to successfully manage this condition.
Read More